Relief Therapeutics Holding Stock Retained Earnings
RLF Stock | CHF 5.10 0.06 1.19% |
Relief Therapeutics Holding fundamentals help investors to digest information that contributes to Relief Therapeutics' financial success or failures. It also enables traders to predict the movement of Relief Stock. The fundamental analysis module provides a way to measure Relief Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Relief Therapeutics stock.
Relief |
Relief Therapeutics Holding Company Retained Earnings Analysis
Relief Therapeutics' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Relief Therapeutics Holding has a Retained Earnings of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The retained earnings for all Switzerland stocks is 100.0% higher than that of the company.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Relief Fundamentals
Return On Equity | -0.33 | |||
Return On Asset | -0.12 | |||
Operating Margin | (5.96) % | |||
Current Valuation | 95.8 M | |||
Shares Outstanding | 4.39 B | |||
Shares Owned By Insiders | 3.68 % | |||
Shares Owned By Institutions | 22.16 % | |||
Price To Earning | 277.00 X | |||
Price To Book | 0.76 X | |||
Price To Sales | 18.81 X | |||
Revenue | 3.32 M | |||
Gross Profit | 2.57 M | |||
EBITDA | (33.3 M) | |||
Net Income | (34.7 M) | |||
Cash And Equivalents | 29.87 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 396 K | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 2.80 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (35.72 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 10 | |||
Beta | -13.71 | |||
Market Capitalization | 114.81 M | |||
Total Asset | 251.62 M | |||
Net Asset | 251.62 M |
About Relief Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Relief Therapeutics Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Relief Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Relief Therapeutics Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.